Pengaruh Pemberian Omega 3 (EPA+DHA) Terhadap Kadar Gula Darah Penderita Diabetes Melitus Tipe 2 di Kota Kendari

The Effect of Omega 3 (EPA+DHA) Supplementation) on Blood Glucose Level in Type 2 Diabetes Mellitus Patient in Kendari

  • Linda Ayu Rizka Putri Program Studi Gizi, Sekolah Tinggi Ilmu Kesehatan Karya Kesehatan, Kendari, Indonesia
  • Ellyani Abadi Program Studi Gizi, Sekolah Tinggi Ilmu Kesehatan Karya Kesehatan, Kendari, Indonesia
DOI: https://doi.org/10.56338/mppki.v5i1.2106
Keywords: T2DM, PUFA, Gula Darah

Abstract

Latar Belakang: Diabetes melitus tipe 2 (T2DM) telah menjadi masalah kesehatan global baik di negara maju maupun negara berkembang. Di Indonesia, prevalensi nasional diabetes meningkat dari 6,9% di tahun 2013 menjadi 8,5% di tahun 2018. Berbagai macam upaya telah dikembangkan guna mengurangi risiko diabetes, diantaranya adalah identifikasi fungsi isoflavone yang berasal dari tumbuh-tumbuhan serta asam lemak tak jenuh Omega 3 seperti eicosapentaenoic acid (EPA) dan docosahexaenoic acid (DHA) yang berasal dari makanan berbasis kelautan. Penelitian ini bertujuan untuk mengetahui pengaruh pemberian Omega 3 komersial (EPA+DHA) terhadap kadar gula darah postprandial penderita DM tipe 2 di Kota Kendari.

Metode: Penelitian ini merupakan penelitian pra eksperimen dengan rancangan one group test pretest-posttest design terhadap 20 penderita DM tipe 2 yang dilaksanakan sejak Agustus sampai Oktober 2021.

Hasil: Hasil penelitian menunjukkan sehingga secara statistik tidak ada perbedaan kadar gula darah postprandial sebelum dan sesudah suplementasi Omega 3 pada pasien diabetes mellitus tipe 2 di Kota Kendari (p value=0.101).

Kesimpulan: Tidak ada perbedaan kadar gula darah postprandial sebelum dan sesudah suplementasi Omega 3 pada pasien diabetes mellitus tipe 2 di Kota Kendari

References

Ogurtsova K, da Rocha Fernandes JD, Huang Y, Linnenkamp U, Guariguata L, Cho NH, et al. IDF Diabetes Atlas: Global estimates for the prevalence of diabetes for 2015 and 2040. Diabetes Res Clin Pract. 2017;128:40–50.

Kesehatan K. Riset Kesehatan Dasar (Riskesdas). Kemenkes RI. 2013;

Larsson SC, Wallin A, Håkansson N, Stackelberg O, Bäck M, Wolk A. Type 1 and type 2 diabetes mellitus and incidence of seven cardiovascular diseases. Int J Cardiol. 2018;262:66–70.

Peters SAE, Huxley RR, Woodward M. Diabetes as risk factor for incident coronary heart disease in women compared with men: a systematic review and meta-analysis of 64 cohorts including 858,507 individuals and 28,203 coronary events. Springer; 2014.

TIME G. ON DIABETES. 2016;

Association AD. Diagnosis and Classification of Diabetes Mellitus. Diabetes Care [Internet]. 2014 Jan 1;37(Supplement 1):S81 LP-S90. Available from: http://care.diabetesjournals.org/content/37/Supplement_1/S81.abstract

Wu JHY, Micha R, Imamura F, Pan A, Biggs ML, Ajaz O, et al. Omega-3 fatty acids and incident type 2 diabetes: a systematic review and meta-analysis. Br J Nutr. 2012;107(S2):S214–27.

Takkunen MJ, Schwab US, de Mello VDF, Eriksson JG, Lindström J, Tuomilehto J, et al. Longitudinal associations of serum fatty acid composition with type 2 diabetes risk and markers of insulin secretion and sensitivity in the Finnish Diabetes Prevention Study. Eur J Nutr [Internet]. 2016;55(3):967–79. Available from: https://doi.org/10.1007/s00394-015-0911-4

Badawi A, Klip A, Haddad P, Cole DE, Bailo BG, El-Sohemy A, et al. Type 2 diabetes mellitus and inflammation: Prospects for biomarkers of risk and nutritional intervention. Diabetes Metab Syndr Obes. 2010 May;3:173–86.

Brown TJ, Brainard J, Song F, Wang X, Abdelhamid A, Hooper L, et al. Omega-3, omega-6, and total dietary polyunsaturated fat for prevention and treatment of type 2 diabetes mellitus: systematic review and meta-analysis of randomised controlled trials. BMJ [Internet]. 2019 Aug 21;366:l4697–l4697. Available from: https://pubmed.ncbi.nlm.nih.gov/31434641

Chang C-H, Tseng P-T, Chen N-Y, Lin P-C, Lin P-Y, Chang JP-C, et al. Safety and tolerability of prescription omega-3 fatty acids: A systematic review and meta-analysis of randomized controlled trials. Prostaglandins, Leukot Essent Fat Acids [Internet]. 2018;129:1–12. Available from: https://www.sciencedirect.com/science/article/pii/S0952327817302910

Published
2021-12-19
How to Cite
Putri, L. A. R., & Ellyani Abadi. (2021). Pengaruh Pemberian Omega 3 (EPA+DHA) Terhadap Kadar Gula Darah Penderita Diabetes Melitus Tipe 2 di Kota Kendari : The Effect of Omega 3 (EPA+DHA) Supplementation) on Blood Glucose Level in Type 2 Diabetes Mellitus Patient in Kendari . Media Publikasi Promosi Kesehatan Indonesia (MPPKI), 5(1), 91-94. https://doi.org/10.56338/mppki.v5i1.2106
Issue
Vol. 5 No. 1: JANUARY 2022 - Media Publikasi Promosi Kesehatan Indonesia (MPPKI)
Section
Research Article

Authors who publish with this journal agree to the following terms:

  1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-Non Commercial License that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
  2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
  3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.

The content of this website is licensed under a Creative Commons Attribution-ShareAlike 4.0 International (CC BY-SA 4.0) license. Creative Commons License